BBLG Q1 2022 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

Q1 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$689,499

Net Income

-$689,499

EPS (Diluted)

$-15.99

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$860,779

Free Cash Flow

-$860,779

Stock-Based Comp.

$152,844

Balance Sheet

Total Assets

$6M

Total Liabilities

$54,913

Stockholders' Equity

$6M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$689,499	-$180,924	-281.1%
Net Income	-$689,499	-$431,747	-59.7%